Viewing Study NCT00016094


Ignite Creation Date: 2025-12-25 @ 1:41 AM
Ignite Modification Date: 2025-12-26 @ 6:47 PM
Study NCT ID: NCT00016094
Status: COMPLETED
Last Update Posted: 2013-01-29
First Post: 2001-05-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma
Sponsor: National Cancer Institute (NCI)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2001-04
Start Date Type: None
Primary Completion Date: 2005-08
Primary Completion Date Type: ACTUAL
Completion Date: 2008-09
Completion Date Type: ACTUAL
First Submit Date: 2001-05-06
First Submit QC Date: None
Study First Post Date: 2003-01-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-01-28
Last Update Post Date: 2013-01-29
Last Update Post Date Type: ESTIMATED